Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Research and Development Expense (Quarterly): 0.057M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.057M |
| June 30, 2024 | 4.36M |
| March 31, 2024 | 3.804M |
| December 31, 2023 | 6.677M |
| September 30, 2023 | 9.527M |
| June 30, 2023 | 10.84M |
| March 31, 2023 | 14.00M |
| December 31, 2022 | 17.04M |
| September 30, 2022 | 15.46M |
| June 30, 2022 | 15.16M |
| March 31, 2022 | 16.29M |
| December 31, 2021 | 17.47M |
| September 30, 2021 | 14.71M |
| June 30, 2021 | 11.90M |
| March 31, 2021 | 11.62M |
| December 31, 2020 | 18.33M |
| September 30, 2020 | 8.274M |
| June 30, 2020 | 11.13M |
| March 31, 2020 | 9.564M |
| Date | Value |
|---|---|
| December 31, 2019 | 13.87M |
| September 30, 2019 | 8.009M |
| June 30, 2019 | 7.023M |
| March 31, 2019 | 7.41M |
| December 31, 2018 | 10.22M |
| September 30, 2018 | 6.316M |
| June 30, 2018 | 3.557M |
| March 31, 2018 | 4.367M |
| December 31, 2017 | 12.61M |
| September 30, 2017 | 2.488M |
| June 30, 2017 | 3.994M |
| March 31, 2017 | 1.281M |
| December 31, 2016 | 6.829M |
| September 30, 2016 | 0.569M |
| June 30, 2016 | 0.582M |
| March 31, 2016 | 0.567M |
| December 31, 2015 | 0.763M |
| September 30, 2015 | 0.57M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.057M
Minimum
Sep 2024
18.33M
Maximum
Dec 2020
11.50M
Average
11.76M
Median
Research and Development Expense (Quarterly) Benchmarks
| Fortress Biotech Inc | 12.67M |
| AIM ImmunoTech Inc | 1.145M |
| Perspective Therapeutics Inc | 9.275M |
| Protalix BioTherapeutics Inc | 2.961M |
| Armata Pharmaceuticals Inc | 8.475M |